7.85
+0.23
+(3.02%)
As of 9:30:40 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Operating Expense
22,668
22,668
7,415
10,363
Operating Income
-22,668
-22,668
-7,415
-10,363
Net Non Operating Interest Income Expense
2,414
2,414
1,423
120
Other Income Expense
-334
-334
-1,216
-3,321
Pretax Income
-20,588
-20,588
-7,208
-13,564
Net Income Common Stockholders
-20,588
-20,588
-7,208
-13,564
Diluted NI Available to Com Stockholders
-20,588
-20,588
-7,208
-13,564
Basic EPS
-0.96
--
-0.56
-1.39
Diluted EPS
-0.96
--
-0.56
-1.39
Basic Average Shares
21,384.38
--
12,909.27
9,732.78
Diluted Average Shares
21,384.38
--
12,909.27
9,732.78
Total Operating Income as Reported
-22,785
-22,785
-7,415
-11,363
Total Expenses
22,668
22,668
7,415
10,363
Net Income from Continuing & Discontinued Operation
-20,588
-20,588
-7,208
-13,564
Normalized Income
-20,254
-20,254
-5,992
-10,243
Interest Income
2,414
2,414
1,423
120
Net Interest Income
2,414
2,414
1,423
120
EBIT
-22,668
-22,668
-7,415
-10,363
EBITDA
-22,652
-22,652
-7,318
-10,253
Reconciled Depreciation
16
16
97
110
Net Income from Continuing Operation Net Minority Interest
-20,588
-20,588
-7,208
-13,564
Total Unusual Items Excluding Goodwill
-334
-334
-1,216
-3,321
Total Unusual Items
-334
-334
-1,216
-3,321
Normalized EBITDA
-22,318
-22,318
-6,102
-6,932
12/31/2022 - 2/13/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SION Sionna Therapeutics, Inc.
8.94
+0.34%
MAZE Maze Therapeutics, Inc.
9.13
+7.41%
MBX MBX Biosciences, Inc.
7.20
-3.10%
UPB Upstream Bio, Inc.
8.12
+7.12%
MTSR Metsera, Inc.
19.86
+9.24%
BCAX Bicara Therapeutics Inc.
11.68
+2.59%
TYRA Tyra Biosciences, Inc.
8.50
+0.83%
CTNM Contineum Therapeutics, Inc.
4.1400
+3.91%
BOLD Boundless Bio, Inc.
1.2500
+0.81%
SRNE Sorrento Therapeutics, Inc.
0.0009
0.00%